| pubmed-article:1737067 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1737067 | lifeskim:mentions | umls-concept:C0003995 | lld:lifeskim |
| pubmed-article:1737067 | lifeskim:mentions | umls-concept:C0036720 | lld:lifeskim |
| pubmed-article:1737067 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:1737067 | lifeskim:mentions | umls-concept:C0052181 | lld:lifeskim |
| pubmed-article:1737067 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
| pubmed-article:1737067 | lifeskim:mentions | umls-concept:C1709915 | lld:lifeskim |
| pubmed-article:1737067 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:1737067 | lifeskim:mentions | umls-concept:C1706204 | lld:lifeskim |
| pubmed-article:1737067 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:1737067 | lifeskim:mentions | umls-concept:C1555721 | lld:lifeskim |
| pubmed-article:1737067 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:1737067 | pubmed:dateCreated | 1992-3-17 | lld:pubmed |
| pubmed-article:1737067 | pubmed:abstractText | We have identified a hitherto unknown genetic polymorphism of apolipoprotein A-IV (apoA-IV). The molecular basis for this polymorphism is an A to G substitution at nucleotide 1687 resulting in an Asn to Ser change of amino acid 127. The frequencies of the two apoA-IV alleles (designated apoA-IV127Asn and apoA-IV127Ser), determined by Hin c II restriction analysis of PCR amplified exon three of the apoA-IV gene, were 0.788 and 0.212, respectively, in a Finnish population sample. Allele frequencies of another polymorphism due to a Thr to Ser substitution at amino acid 347 were determined using Hinf I restriction analysis. The allele frequencies were 0.823 for apoA-IV347Thr and 0.177 for apoA-IV347Ser. None of the apoA-IV polymorphisms (apoA-IV127:Asn----Ser, apoA-IV347:Thr----Ser and apoA-IV360:Gln----His) had any effect on plasma lipid and lipoprotein concentrations in cohorts of dyslipidemic men and in a population sample of normolipidemic controls. There was also no association between the history of previous myocardial infarction and any of the apoA-IV alleles. | lld:pubmed |
| pubmed-article:1737067 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1737067 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1737067 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1737067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1737067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1737067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1737067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1737067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1737067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1737067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1737067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1737067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1737067 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1737067 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:1737067 | pubmed:issn | 0006-3002 | lld:pubmed |
| pubmed-article:1737067 | pubmed:author | pubmed-author:ManninenVV | lld:pubmed |
| pubmed-article:1737067 | pubmed:author | pubmed-author:TaskinenM RMR | lld:pubmed |
| pubmed-article:1737067 | pubmed:author | pubmed-author:BaumannMM | lld:pubmed |
| pubmed-article:1737067 | pubmed:author | pubmed-author:KontulaKK | lld:pubmed |
| pubmed-article:1737067 | pubmed:author | pubmed-author:KoskinenPP | lld:pubmed |
| pubmed-article:1737067 | pubmed:author | pubmed-author:Kauppinen-Mäk... | lld:pubmed |
| pubmed-article:1737067 | pubmed:author | pubmed-author:LukkaMM | lld:pubmed |
| pubmed-article:1737067 | pubmed:author | pubmed-author:TenkanenHH | lld:pubmed |
| pubmed-article:1737067 | pubmed:author | pubmed-author:MänttäriMM | lld:pubmed |
| pubmed-article:1737067 | pubmed:author | pubmed-author:MetsoJJ | lld:pubmed |
| pubmed-article:1737067 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1737067 | pubmed:day | 16 | lld:pubmed |
| pubmed-article:1737067 | pubmed:volume | 1138 | lld:pubmed |
| pubmed-article:1737067 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1737067 | pubmed:authorsComplete | N | lld:pubmed |
| pubmed-article:1737067 | pubmed:pagination | 27-33 | lld:pubmed |
| pubmed-article:1737067 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:meshHeading | pubmed-meshheading:1737067-... | lld:pubmed |
| pubmed-article:1737067 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1737067 | pubmed:articleTitle | A novel polymorphism of apolipoprotein A-IV is the result of an asparagine to serine substitution at residue 127. | lld:pubmed |
| pubmed-article:1737067 | pubmed:affiliation | National Public Health Institute, First Department of Medicine, Helsinki, Finland. | lld:pubmed |
| pubmed-article:1737067 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1737067 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:337 | entrezgene:pubmed | pubmed-article:1737067 | lld:entrezgene |
